FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154353367> ?p ?o ?g. }

• W3154353367 endingPage "845" @default.
• W3154353367 startingPage "837" @default.
• W3154353367 abstract "Background Anaplastic thyroid cancer (ATC) has dismal prognosis and there is no effective treatment. We aimed to evaluate the efficacy of tyrosine kinase inhibitor (TKI) therapy in real-world clinic and to suggest the most effective treatment modality according to the combination of treatments. Methods This retrospective study evaluated clinical outcomes and cause of death with multimodal treatments in patients with ATC at Samsung Medical Center. Results A total of 120 patients received anti-cancer treatment for ATC. Seventy-seven (64.2%) patients underwent surgery, 64 (53.3%) received radiotherapy, 29 (24.2%) received cytotoxic chemotherapy, and 19 (15.8%) received TKI therapy. In the TKI therapy group, eight achieved partial response (three with lenvatinib and five with dabrafenib plus trametinib), and two patients with lenvatinib showed stable disease. Median progression-free survival (PFS) of the TKI therapy group was 2.7 months (range: 0.1–12.7) and their median overall survival (OS) was 12.4 months (range: 1.7–47.7). Patients who received surgery or radiotherapy for local control showed superior OS than those who did not. In a multivariate analysis, surgery, TKI therapy, younger age, and no distant metastasis were associated with favorable OS. The combination of surgery, radiotherapy, and TKI therapy (median OS: 34.3 months, 6-month survival rates: 77.8%) was the most effective. Compared to the era without TKI therapy, distant metastasis has recently become the major cause of death in ATC over airway problems. Conclusions Multimodality treatment including TKI therapy demonstrated prolonged survival with dabrafenib plus trametinib as the most effective therapeutic option demonstrated for BRAF mutant ATC patients." @default.
• W3154353367 created "2021-04-26" @default.
• W3154353367 creator A5003283147 @default.
• W3154353367 creator A5004152384 @default.
• W3154353367 creator A5013257516 @default.
• W3154353367 creator A5030107272 @default.
• W3154353367 creator A5034739279 @default.
• W3154353367 creator A5051549679 @default.
• W3154353367 creator A5066161983 @default.
• W3154353367 creator A5066858978 @default.
• W3154353367 creator A5072267593 @default.
• W3154353367 creator A5080452700 @default.
• W3154353367 date "2021-06-01" @default.
• W3154353367 modified "2023-09-30" @default.
• W3154353367 title "Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience" @default.
• W3154353367 cites W1986861417 @default.
• W3154353367 cites W2019607817 @default.
• W3154353367 cites W2154576579 @default.
• W3154353367 cites W2156078931 @default.
• W3154353367 cites W2911232639 @default.
• W3154353367 cites W887587423 @default.
• W3154353367 doi "https://doi.org/10.1530/eje-20-1482" @default.
• W3154353367 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33852431" @default.
• W3154353367 hasPublicationYear "2021" @default.
• W3154353367 type Work @default.
• W3154353367 sameAs 3154353367 @default.
• W3154353367 citedByCount "14" @default.
• W3154353367 countsByYear W31543533672021 @default.
• W3154353367 countsByYear W31543533672022 @default.
• W3154353367 countsByYear W31543533672023 @default.
• W3154353367 crossrefType "journal-article" @default.
• W3154353367 hasAuthorship W3154353367A5003283147 @default.
• W3154353367 hasAuthorship W3154353367A5004152384 @default.
• W3154353367 hasAuthorship W3154353367A5013257516 @default.
• W3154353367 hasAuthorship W3154353367A5030107272 @default.
• W3154353367 hasAuthorship W3154353367A5034739279 @default.
• W3154353367 hasAuthorship W3154353367A5051549679 @default.
• W3154353367 hasAuthorship W3154353367A5066161983 @default.
• W3154353367 hasAuthorship W3154353367A5066858978 @default.
• W3154353367 hasAuthorship W3154353367A5072267593 @default.
• W3154353367 hasAuthorship W3154353367A5080452700 @default.
• W3154353367 hasBestOaLocation W31543533671 @default.
• W3154353367 hasConcept C121608353 @default.
• W3154353367 hasConcept C126322002 @default.
• W3154353367 hasConcept C141071460 @default.
• W3154353367 hasConcept C143998085 @default.
• W3154353367 hasConcept C184235292 @default.
• W3154353367 hasConcept C2776131300 @default.
• W3154353367 hasConcept C2776264508 @default.
• W3154353367 hasConcept C2776694085 @default.
• W3154353367 hasConcept C2776999253 @default.
• W3154353367 hasConcept C2778472372 @default.
• W3154353367 hasConcept C2778820342 @default.
• W3154353367 hasConcept C2778830669 @default.
• W3154353367 hasConcept C2779761222 @default.
• W3154353367 hasConcept C2780256643 @default.
• W3154353367 hasConcept C2780739268 @default.
• W3154353367 hasConcept C2994587330 @default.
• W3154353367 hasConcept C509974204 @default.
• W3154353367 hasConcept C57074206 @default.
• W3154353367 hasConcept C71924100 @default.
• W3154353367 hasConcept C86803240 @default.
• W3154353367 hasConcept C95444343 @default.
• W3154353367 hasConceptScore W3154353367C121608353 @default.
• W3154353367 hasConceptScore W3154353367C126322002 @default.
• W3154353367 hasConceptScore W3154353367C141071460 @default.
• W3154353367 hasConceptScore W3154353367C143998085 @default.
• W3154353367 hasConceptScore W3154353367C184235292 @default.
• W3154353367 hasConceptScore W3154353367C2776131300 @default.
• W3154353367 hasConceptScore W3154353367C2776264508 @default.
• W3154353367 hasConceptScore W3154353367C2776694085 @default.
• W3154353367 hasConceptScore W3154353367C2776999253 @default.
• W3154353367 hasConceptScore W3154353367C2778472372 @default.
• W3154353367 hasConceptScore W3154353367C2778820342 @default.
• W3154353367 hasConceptScore W3154353367C2778830669 @default.
• W3154353367 hasConceptScore W3154353367C2779761222 @default.
• W3154353367 hasConceptScore W3154353367C2780256643 @default.
• W3154353367 hasConceptScore W3154353367C2780739268 @default.
• W3154353367 hasConceptScore W3154353367C2994587330 @default.
• W3154353367 hasConceptScore W3154353367C509974204 @default.
• W3154353367 hasConceptScore W3154353367C57074206 @default.
• W3154353367 hasConceptScore W3154353367C71924100 @default.
• W3154353367 hasConceptScore W3154353367C86803240 @default.
• W3154353367 hasConceptScore W3154353367C95444343 @default.
• W3154353367 hasIssue "6" @default.
• W3154353367 hasLocation W31543533671 @default.
• W3154353367 hasLocation W31543533672 @default.
• W3154353367 hasOpenAccess W3154353367 @default.
• W3154353367 hasPrimaryLocation W31543533671 @default.
• W3154353367 hasRelatedWork W2766581537 @default.
• W3154353367 hasRelatedWork W2769724680 @default.
• W3154353367 hasRelatedWork W2896110923 @default.
• W3154353367 hasRelatedWork W2966674226 @default.
• W3154353367 hasRelatedWork W3138443913 @default.
• W3154353367 hasRelatedWork W3154353367 @default.
• W3154353367 hasRelatedWork W4206933536 @default.
• W3154353367 hasRelatedWork W4281966242 @default.
• W3154353367 hasRelatedWork W4282969012 @default.

• next